LIPIDEON BIOTECHNOLOGY AG
Lipideon Biotechnology AG is a Swiss stock company founded in Zurich as an ETH spin-off by Dr. Helmut Hauser in 2002. They are a drug R&D company, focusing on the treatment of arteriosclerosis and related cardiovascular diseases. Their strategy is to develop a new class of non-absorbable drugs that inhibit cholesterol absorption in the small intestine and as a result reduce serum cholesterol levels. This carries the potential for safer and improved treatment of dyslipidemia, the main underlying... cause of artherosclerosis that eventually leads to stroke and heart attacks. Arteriosclerosis is a major health problem in Western industrialized nations affecting more than 50% of the total population and an increasing number of people in the rest of the world. Cholesterol-lowering drugs have reached worldwide sales of $ 34.7 billion in 2007.
LIPIDEON BIOTECHNOLOGY AG
Industry:
Biotechnology Medical
Founded:
2002-01-01
Address:
Zรผrich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.lipideon.com
Status:
Closed
Contact:
+41 (0)44 200 90 97
Email Addresses:
[email protected]
Similar Organizations
ExpreS2ion
ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.
More informations about "Lipideon Biotechnology AG"
Lipideon Biotechnology AG - Crunchbase Company Profile
Lipideon Biotechnology AG is a Swiss stock company founded in Zurich as an ETH spin-off by Dr. Helmut Hauser in 2002. They are a drug R&D company, focusing on the treatment of โฆSee details»
Lipideon Biotechnology AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Lipideon Biotechnology AG of Zรผrich, ZรRICH. Get the latest business insights from Dun & Bradstreet.See details»
Lipideon - Products, Competitors, Financials, Employees, โฆ
Lipideon is a developer of non-absorbable drugs that inhibit cholesterol absorption in the small intestine, reducing serum cholesterol levels. Use the CB Insights Platform to explore โฆSee details»
Lipideon Biotechnology AG - Crunchbase
Lipideon Biotechnology AG is a drug R&D company, focusing on the treatment of arteriosclerosis and related cardiovascular diseases.See details»
Lipideon Biotechnology AG - VentureRadar
Website: http://www.lipideon.com/ Lipideon Biotechnology AG is a Swiss stock company founded in Zurich as an ETH spin-off by Dr. Helmut Hauser in 2002. We are a drug R&D company, โฆSee details»
Lipideon Biotechnology AG - Drug pipelines, Patents, Clinical trials ...
Explore Lipideon Biotechnology AG with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:LPD-608.See details»
Lipideon Biotechnology AG - venture.ch
Lipideon focuses on the discovery and development of medication, which prevents or reduces the cholesterol- and fat resorption in the small intestine .See details»
Lipideon Biotechnology AG - Tech Stack, Apps, Patents
Lipideon Biotechnology AG is a drug R&D company, focusing on the treatment of arteriosclerosis and related cardiovascular diseases.See details»
Lipideon Biotechnology AG โ Swiss Biotech
Discover if your new anti-cancer drug will work! Our validated platform uses intact patients tumors, maintains their complexity and cellular component, and overcomes organoids. This allows to โฆSee details»
Erhard Edwin Lee: Positions, Relations and Network - MarketScreener
Dec 31, 2000ย ยท Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. โฆSee details»
Patents Assigned to Lipideon Biotechnology AG
Abstract: The present invention relates to novel hypocholesterolemic compounds of formula (I) useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol โฆSee details»
Lipideon Biotechnology AG - VentureRadar
Lipideon Biotechnology AG is a Swiss stock company founded in Zurich as an ETH spin-off by Dr. Helmut Hauser in 2002. We are a drug R&D company, focusing on the treatment of โฆSee details»
Research programme: cholesterol absorption inhibitors - Lipideon ...
Lipideon Biotechnology AG, an ETH Zurich (Swiss Federal Institute of Technology Zurich) spin-off company, is developing second-generation, non-absorbable smallSee details»
Synergene Biotech - VentureRadar
Lipideon Biotechnology AG is a Swiss stock company founded in Zurich as an ETH spin-off by Dr. Helmut Hauser in 2002. We are a drug R&D company, focusing on the treatment of โฆSee details»
Thomas Fessard - Co-Founder & CEO @ SpiroChem AG
After research appointments at the School of Pharmacy in Nottingham and ETH Zรผrich, Thomas joined Lipideon Biotechnology AG in 2007. As Head of the Drug Discovery and Chemistry, he โฆSee details»
Lipideon Management Team - CB Insights
Explore {Lipideon's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
LPD-608 - Drug Targets, Indications, Patents - Synapse - Patsnap
LPD-608: a ฮฒ-lactamase inhibitors Drug, Initially developed by Lipideon Biotechnology AG, Now, its global highest R&D status is Pending, Mechanism: ฮฒ-lactamase inhibitors (Beta Lactamase โฆSee details»
Lipotropic Injections Benefits, Side Effects, Dosage, and Cost
Nov 14, 2024ย ยท Lipotropic injections are supplements people use for fat loss. These aim to complement other aspects of a weight loss regimen, including exercise and a low calorie diet. โฆSee details»
Lipotropic injections: Cost, dosage, and risks - Medical News Today
Apr 17, 2023ย ยท Lipotropic injections contain combinations of vitamins and other substances, and some clinics offer them for weight loss. However, research has not confirmed they are safe or โฆSee details»
Inovalab Corp. - VentureRadar
Inovalab AG is a Swiss Contract Research Organization founded in 1999 offering a wide range of services in research and development of pharmaceutical compounds. Since 2000, Inovalab โฆSee details»